Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,906 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine.
Tan YS, Sansanaphongpricha K, Xie Y, Donnelly CR, Luo X, Heath BR, Zhao X, Bellile E, Hu H, Chen H, Polverini PJ, Chen Q, Young S, Carey TE, Nör JE, Ferris RL, Wolf GT, Sun D, Lei YL. Tan YS, et al. Among authors: young s. Clin Cancer Res. 2018 Sep 1;24(17):4242-4255. doi: 10.1158/1078-0432.CCR-17-2807. Epub 2018 May 16. Clin Cancer Res. 2018. PMID: 29769207 Free PMC article.
Anti-tumor immunity induced by ectopic expression of viral antigens is transient and limited by immune escape.
Dharmaraj N, Piotrowski SL, Huang C, Newton JM, Golfman LS, Hanoteau A, Koshy ST, Li AW, Pulikkathara MX, Zhang B, Burks JK, Mooney DJ, Lei YL, Sikora AG, Young S. Dharmaraj N, et al. Among authors: young s. Oncoimmunology. 2019 Feb 6;8(4):e1568809. doi: 10.1080/2162402X.2019.1568809. eCollection 2019. Oncoimmunology. 2019. PMID: 30906661 Free PMC article.
HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING.
Luo X, Donnelly CR, Gong W, Heath BR, Hao Y, Donnelly LA, Moghbeli T, Tan YS, Lin X, Bellile E, Kansy BA, Carey TE, Brenner JC, Cheng L, Polverini PJ, Morgan MA, Wen H, Prince ME, Ferris RL, Xie Y, Young S, Wolf GT, Chen Q, Lei YL. Luo X, et al. Among authors: young s. J Clin Invest. 2020 Apr 1;130(4):1635-1652. doi: 10.1172/JCI129497. J Clin Invest. 2020. PMID: 31874109 Free PMC article.
Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition.
Newton JM, Hanoteau A, Liu HC, Gaspero A, Parikh F, Gartrell-Corrado RD, Hart TD, Laoui D, Van Ginderachter JA, Dharmaraj N, Spanos WC, Saenger Y, Young S, Sikora AG. Newton JM, et al. Among authors: young s. J Immunother Cancer. 2019 Aug 13;7(1):216. doi: 10.1186/s40425-019-0698-6. J Immunother Cancer. 2019. PMID: 31409394 Free PMC article. Clinical Trial.
Biomaterial-Facilitated Immunotherapy for Established Oral Cancers.
Leach DG, Dharmaraj N, Lopez-Silva TL, Venzor JR, Pogostin BH, Sikora AG, Hartgerink JD, Young S. Leach DG, et al. Among authors: young s. ACS Biomater Sci Eng. 2021 Feb 8;7(2):415-421. doi: 10.1021/acsbiomaterials.0c01575. Epub 2021 Jan 20. ACS Biomater Sci Eng. 2021. PMID: 33470801 Free PMC article.
Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy.
Muñoz NM, Williams M, Dixon K, Dupuis C, McWatters A, Avritscher R, Manrique SZ, McHugh K, Murthy R, Tam A, Naing A, Patel SP, Leach D, Hartgerink JD, Young S, Prakash P, Hwu P, Sheth RA. Muñoz NM, et al. Among authors: young s. J Immunother Cancer. 2021 Feb;9(2):e001800. doi: 10.1136/jitc-2020-001800. J Immunother Cancer. 2021. PMID: 33589526 Free PMC article.
Oral squamous cell carcinoma outcome in adolescent/young adult: Systematic review and meta-analysis.
Kaminagakura E, Tango RN, Cruz-Perez D, Bonan R, Yamamoto de Almeida L, de Almeida Lança ML, Bonan P, Martins H, Takahama A Jr, Ito FA, Coutinho-Camillo CM, Lourenço SV, Caneppele T, Sikora AG, Kowalski LP, Young S. Kaminagakura E, et al. Among authors: young s. Head Neck. 2022 Feb;44(2):548-561. doi: 10.1002/hed.26940. Epub 2021 Nov 22. Head Neck. 2022. PMID: 34808012 Review.
5,906 results